
	Three Months Ended June 30,
	2026		2025
Numerator:
Net income (loss)	$	745	$	(7,030)
Less: Earnings attributable to participating securities	$	—	$	—
Net income (loss) attributable to common stockholders—basic and diluted	$	745	$	(7,030)
Denominator:
Weighted average common shares outstanding—basic	8,784,395		8,460,447

Effect of potentially dilutive share-based awards	—		—

Weighted average common shares outstanding—diluted	8,784,395		8,460,447

Net income (loss) per share attributable to common stockholders - basic and diluted	$	0.08	$	(0.83)

For the three months ended June 30, 2026 and 2025, the Company excluded the following potential dilutive securities, which include stock options, RSUs, warrants and convertible notes from the computation of diluted net loss and earnings per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of shares of common stock outstanding used to calculate both basic and diluted net loss and earnings per share attributable to common stockholders is the same for the three months ended June 30, 2026 and 2025.


	As of	As of
	June 30,	June 30,
	2026	2025
Stock options to purchase common stock	397,449	451,792
Restricted stock units	772,015	1,252,739
Warrants to purchase common stock	—	651,817
2025 Convertible Notes as converted to common stock	—	221,276
Employee Stock Purchase Plan	9,591	18,887